Anne Li October 28th, 2017
Blood cancer patients most susceptible to a potentially fatal side effect of immunotherapy called neurotoxicity could be identified by looking for specific markers, according to a new US study. The team, from the Fred Hutchinson Cancer Research Centre, identified a number of potential biomarkers that could help doctors identify those most at risk of damage to the brain or nervous system (neurotoxicity) after CAR T cell therapy.
See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-10-13-new-markers-could-identify-patients-most-at-risk-of-brain-damage-from-car-t-cell-immunotherapy
Post a comment